Clinical trials
Encephalitis, Japanese trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
72 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 11 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 9 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 2 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 60 |
| Unknown status | 8 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Valneva Austria GmbH | 15 |
| Sanofi Pasteur, a Sanofi Company | 11 |
| PATH | 7 |
| Sanofi | 7 |
| Liaoning Chengda Biotechnology CO., LTD | 3 |
| National Institute of Hygiene and Epidemiology, Vietnam | 3 |
| Boryung Pharmaceutical Co., Ltd | 2 |
| Novartis | 2 |
| Singapore General Hospital | 2 |
| University of Liverpool | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Encephalitis, Japanese | 72 |
| Encephalitis | 6 |
| Measles | 5 |
| Rubella | 5 |
| Yellow Fever | 5 |
| Mumps | 4 |
| Chickenpox | 3 |
| Hepatitis A | 3 |
| Rabies | 3 |
| Communicable Diseases | 2 |
Trials
Showing 76 to 72 of 72. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.